Patent Assignment
Reel/Frame 070421/0835
Security Interest
Recorded: 2025-03-06
Pages: 9
Assignor
AVISTA PHARMA SOLUTIONS, INC.
Executed: 2025-03-06
Assignee
ARES AGENT SERVICES, L.P., AS COLLATERAL AGENT
245 PARK AVENUE, NEW YORK, NEW YORK, 10167
Covered Properties
(8)
Antiparasitic Compounds
A COMPOUND 1-[2-[4-(2-ETHYL-6,8-DIMETHYLIMIDAZO[1,2-a]PYRAZIN-3-YL)PHENYL]ETHYL]-3-(p-TOLYLSULFONYL)UREA AS A PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST
Patent:
10,239,885 →
Application:
16/100,315 →
Antiparasitic Compounds
Substituted Ureas as Prostaglandin EP4 Receptor Antagonists
Synthetic Process and Intermediates
Synthetic Process and Intermediates
Chemical Compounds
Chemical Compounds
Application:
17/903,216 →
Publication:
US 2023/0029009
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 2, 2018
From: SPEAKE, JASON D.
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 047031/0830 →
Security Interest
Feb 1, 2019
From: AVISTA PHARMA SOLUTIONS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048218/0762 →
Second Lien Patent Security Agreement
Dec 4, 2019
From: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051196/0080 →
Notice of Release of Security Interest in Patents
Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 051196/0092 →
First Lien Patent Security Agreement
Dec 4, 2019
From: AVISTA PHARMA SOLUTIONS, INC.; CAMBREX CHARLES CITY, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051283/0877 →
Release of Second Lien Security Interest in Patents
Dec 7, 2020
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 054630/0307 →
Assignment of Assignor's Interest
Sep 27, 2022
From: SPEAKE, JASON D.; PERALES, JOE B.; BECK, BRENT CHRISTOPHER; PANDI, BHARATHI
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 061223/0389 →
Release of First Lien Security Interest in Patents
Mar 6, 2025
From: ROYAL BANK OF CANADA
To: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.; SNAPDRAGON CHEMISTRY, INC.
Reel/Frame 070438/0333 →
Assignment and Assumption of Intellectual Property Security Agreement
Apr 11, 2025
From: ARES AGENT SERVICES, L.P., AS FORMER AGENT
To: BLUE OWL CAPITAL CORPORATION, AS NEW AGENT
Reel/Frame 070821/0302 →